Loading...
Brain metastases in non-small-cell lung cancer: are tyrosine kinase inhibitors and checkpoint inhibitors now viable options?
Significant progress has been made in the treatment of stage iv non-small-cell lung cancer (nsclc); however, the prognosis of patients with brain metastases remains poor. Resection and radiation therapy remain standard options. This issue is an important one because 10% of patients with nsclc have b...
Na minha lista:
| Udgivet i: | Curr Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Multimed Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6001769/ https://ncbi.nlm.nih.gov/pubmed/29910653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.25.3733 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|